American Century Companies
EVMN

American Century Companies’s Evommune Inc EVMN Stock Holding History

American Century Companies’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10M Buy
755,018
+262,080
+53% +$6.09M ﹤0.01% 1567
2026
Q1 		$11.3M Buy
492,938
+75,483
+18% +$1.71M 0.01% 1418
2025
Q4 		$7.15M Buy
+417,455
New +$7.84M ﹤0.01% 1589

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

American Century Companies's EVMN Position: Q2 2026 in Review

American Century Companies increased its Evommune Inc (EVMN) stake by 53% in Q2 2026, buying an estimated $6.09M and bringing the position to 755,018 shares worth $10M. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

American Century Companies first reported a position in EVMN in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.3M in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • American Century Companies held 755,018 shares of Evommune Inc worth $10M as of Q2 2026.
  • American Century Companies bought 262,080 Evommune Inc shares in Q2 2026, an estimated $6.09M.
  • Evommune Inc made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1567 holding.
  • American Century Companies first reported a position in Evommune Inc in Q4 2025 and has held it in 3 quarters since.
  • American Century Companies's Evommune Inc position peaked at $11.3M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.